Announcements

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Metastasis”, which are listed below:

1. “Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis”
by Mohammadrasul Zareinejad, Fereshteh Mehdipour, Mina Roshan-Zamir, Zahra Faghih and Abbas Ghaderi
Cancers 2023, 15(19), 4771; https://doi.org/10.3390/cancers15194771
Available online: https://www.mdpi.com/2072-6694/15/19/4771

2. “KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies”
by Alessandro Ottaiano, Francesco Sabbatino, Francesco Perri, Marco Cascella, Roberto Sirica, Renato Patrone, Maurizio Capuozzo, Giovanni Savarese, Monica Ianniello, Nadia Petrillo et al.
Cancers 2023, 15(14), 3579; https://doi.org/10.3390/cancers15143579
Available online: https://www.mdpi.com/2072-6694/15/14/3579

3. “The Importance of Optimal Thermal Ablation Margins in Colorectal Liver Metastases: A Systematic Review and Meta-Analysis of 21 Studies”
by David-Dimitris Chlorogiannis, Vlasios S. Sotirchos, Christos Georgiades, Dimitrios Filippiadis, Ronald S. Arellano, Mithat Gonen, Gregory C. Makris, Tushar Garg and Constantinos T. Sofocleous
Cancers 2023, 15(24), 5806; https://doi.org/10.3390/cancers15245806
Available online: https://www.mdpi.com/2072-6694/15/24/5806

4. “Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review”
by Milena Matuszczak, Adam Kiljańczyk and Maciej Salagierski
Cancers 2023, 15(6), 1804; https://doi.org/10.3390/cancers15061804
Available online: https://www.mdpi.com/2072-6694/15/6/1804

5. “Differential Impact of Exercises on Quality-of-Life Improvement in Breast Cancer Survivors: A Network Meta-Analysis of Randomized Controlled Trials”
by Tzu-Chieh Wang, Pei-Lun Chen, Wan-Chun Liao and I-Chen Tsai
Cancers 2023, 15(13), 3380; https://doi.org/10.3390/cancers15133380
Available online: https://www.mdpi.com/2072-6694/15/13/3380

6. “Survival, Treatment Outcome, and Safety of Multiple and Repeated Courses of Stereotactic Body Radiotherapy for Pulmonary Oligometastases of Head and Neck Squamous Cell Carcinoma”
by Samuel Moritz Vorbach, Julian Mangesius, Daniel Dejaco, Thomas Seppi, Matthias Santer, Stephanie Zur Nedden, Manuel Paolo Sarcletti, Martin Josef Pointner, Tilmann Jakob Hart, Herbert Riechelmann et al.
Cancers 2023, 15(21), 5253; https://doi.org/10.3390/cancers15215253
Available online: https://www.mdpi.com/2072-6694/15/21/5253

7. “Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations”
by Yusuke Tomita, Shinya Sakata, Kosuke Imamura, Shinji Iyama, Takayuki Jodai, Koichi Saruwatari, Shohei Hamada, Kimitaka Akaike, Moriyasu Anai, Kazuaki Fukusima et al.
Cancers 2023, 15(1), 47; https://doi.org/10.3390/cancers16010047
Available online: https://www.mdpi.com/2072-6694/16/1/47

8. “A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group”
by Giulia Marvaso, Federico Mastroleo, Giulia Corrao, Mattia Zaffaroni, Maria Giulia Vincini, Paolo Borghetti, Francesco Cuccia, Manuela Federico, Giampaolo Montesi, Antonio Pontoriero et al.  
Cancers 2023, 15(15), 3902; https://doi.org/10.3390/cancers15153902
Available online: https://www.mdpi.com/2072-6694/15/15/3902

9. “Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma”
by Luca Ielasi, Francesco Tovoli, Matteo Tonnini, Bernardo Stefanini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Ingrid Garajová et al.
Cancers 2023, 15(5), 1523; https://doi.org/10.3390/cancers15051523
Available online: https://www.mdpi.com/2072-6694/15/5/1523

10. “Breast Cancer and Bone Mineral Density in a U.S. Cohort of Middle-Aged Women: Associations with Phosphate Toxicity”
by Ronald B. Brown, Philip Bigelow and Joel A. Dubin
Cancers 2023, 15(20), 5093; https://doi.org/10.3390/cancers15205093
Available online: https://www.mdpi.com/2072-6694/15/20/5093

11. “BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature”
by Patricia Guerrero, Víctor Albarrán, María San Román, Carlos González-Merino, Coral García de Quevedo, Jaime Moreno, Juan Carlos Calvo, Guillermo González, Inmaculada Orejana, Jesús Chamorro et al.
Cancers 2023, 15(21), 5243; https://doi.org/10.3390/cancers15215243
Available online: https://www.mdpi.com/2072-6694/15/21/5243

12. “Computational Modeling of Thermal Ablation Zones in the Liver: A Systematic Review”
by Gonnie C. M. van Erp, Pim Hendriks, Alexander Broersen, Coosje A. M. Verhagen, Faeze Gholamiankhah, Jouke Dijkstra and Mark C. Burgmans
Cancers 2023, 15(23), 5684; https://doi.org/10.3390/cancers15235684
Available online: https://www.mdpi.com/2072-6694/15/23/5684

13. “In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma”
by Robin G. Rajan, Virneliz Fernandez-Vega, Jantzen Sperry, Jonathan Nakashima, Long H. Do, Warren Andrews, Simina Boca, Rezwanul Islam, Sajeel A. Chowdhary, Jan Seldin, Glauco R. Souza et al.
Cancers 2023, 15(13), 3289; https://doi.org/10.3390/cancers15133289
Available online: https://www.mdpi.com/2072-6694/15/13/3289

14. “A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes”
by Guang Yang, Xi (Richard) Yu, Daniel J. Weisenberger, Tao Lu and Gangning Liang
Cancers 2023, 15(11), 2934; https://doi.org/10.3390/cancers15112934
Available online: https://www.mdpi.com/2072-6694/15/11/2934

15. “The Management of Metastatic Spinal Cord Compression in Routine Clinical Practice”
by Luis Alberto Pérez-Romasanta, Estanislao Arana, Francisco M. Kovacs and Ana Royuela
Cancers 2023, 15(10), 2821; https://doi.org/10.3390/cancers15102821
Available online: https://www.mdpi.com/2072-6694/15/10/2821

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Immunology and Immunotherapy”, which are listed below:

1. “Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential”
by Kaushik Das, Subhojit Paul, Arnab Ghosh, Saurabh Gupta, Tanmoy Mukherjee, Prem Shankar, Anshul Sharma, Shiva Keshava, Subhash C. Chauhan, Vivek Kumar Kashyap et al.
Cancers 2023, 15(19), 4879; https://doi.org/10.3390/cancers15194879
Available online: https://www.mdpi.com/2072-6694/15/19/4879

2. “Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy”
by Neta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff, Shirly Grynberg, Jacob Schachter, Ronnie Shapira-Frommer and Nethanel Asher
Cancers 2023, 15(11), 3041; https://doi.org/10.3390/cancers15113041
Available online: https://www.mdpi.com/2072-6694/15/11/3041

3. “Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines”
by Freddy Elad Essogmo, Angelina V. Zhilenkova, Yvan Sinclair Ngaha Tchawe, Abah Moses Owoicho, Alexander S. Rusanov, Alexander Boroda, Yuliya N. Pirogova, Zaiana D. Sangadzhieva, Varvara D. Sanikovich, Nikolay N. Bagmet et al.
Cancers 2023, 15(22), 5383; https://doi.org/10.3390/cancers15225383
Available online: https://www.mdpi.com/2072-6694/15/22/5383

4. “Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer”
by Kirti Agrawal, Shailendra Asthana and Dhruv Kumar
Cancers 2023, 15(20), 4920; https://doi.org/10.3390/cancers15204920
Available online: https://www.mdpi.com/2072-6694/15/20/4920

5. “TIGIT Expression on Activated NK Cells Correlates with Greater Anti-Tumor Activity but Promotes Functional Decline upon Lung Cancer Exposure: Implications for Adoptive Cell Therapy and TIGIT-Targeted Therapies”
by Md Faqrul Hasan, Tayler J. Croom-Perez, Jeremiah L. Oyer, Thomas A. Dieffenthaller, Liza D. Robles-Carrillo, Jonathan E. Eloriaga, Sanjana Kumar, Brendan W. Andersen and Alicja J. Copik
Cancers 2023, 15(10), 2712; https://doi.org/10.3390/cancers15102712
Available online: https://www.mdpi.com/2072-6694/15/10/2712

6. “Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults”
by Meagan Mandabach Olivet, Michael C. Brown, Zachary J. Reitman, David M. Ashley, Gerald A. Grant, Yuanfan Yang and James M. Markert
Cancers 2023, 15(15), 3901; https://doi.org/10.3390/cancers15153901
Available online: https://www.mdpi.com/2072-6694/15/15/3901

7. “Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs”
by Elin M. V. Forsberg, Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Valentina Bucher, Akseli E. Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M. Nilsson et al.
Cancers 2023, 15(3), 648; https://doi.org/10.3390/cancers15030648
Available online: https://www.mdpi.com/2072-6694/15/3/648

8. “Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes?”
by Jonathan Thouvenin, Claire Masson, Philippe Boudier, Denis Maillet, Sabine Kuchler-Bopp, Philippe Barthélémy and Thierry Massfelder
Cancers 2023, 15(3), 793; https://doi.org/10.3390/cancers15030793
Available online: https://www.mdpi.com/2072-6694/15/3/793

9. “Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation”
by Eleonora Sosa Cuevas, Philippe Saas and Caroline Aspord
Cancers 2023, 15(8), 2206; https://doi.org/10.3390/cancers15082206
Available online: https://www.mdpi.com/2072-6694/15/8/2206

10. “Bispecific Antibodies in Hematological Malignancies: A Scoping Review”
by Mohamed H. Omer, Areez Shafqat, Omar Ahmad, Khaled Alkattan, Ahmed Yaqinuddin and Moussab Damlaj
Cancers 2023, 15(18), 4550; https://doi.org/10.3390/cancers15184550
Available online: https://www.mdpi.com/2072-6694/15/18/4550

11. “B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma”
by Cristina Bottino, Chiara Vitale, Alessandra Dondero and Roberta Castriconi
Cancers 2023, 15(13), 3279; https://doi.org/10.3390/cancers15133279
Available online: https://www.mdpi.com/2072-6694/15/13/3279

12. “FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer”
by Peter Grell, Simona Borilova, Pavel Fabian, Iveta Selingerova, David Novak, Petr Muller, Igor Kiss and Rostislav Vyzula
Cancers 2023, 15(6), 1901; https://doi.org/10.3390/cancers15061901
Available online: https://www.mdpi.com/2072-6694/15/6/1901

13. “Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines”
by Elisabetta Mereu, Damiano Abbo, Tina Paradzik, Michela Cumerlato, Cecilia Bandini, Maria Labrador, Monica Maccagno, Domenica Ronchetti, Veronica Manicardi, Antonino Neri et al.
Cancers 2023, 15(8), 2199; https://doi.org/10.3390/cancers15082199
Available online: https://www.mdpi.com/2072-6694/15/8/2199

14. “Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy”
by Aleksandra Basek, Grzegorz K. Jakubiak, Grzegorz Cieślar and Agata Stanek
Cancers 2023, 15(24), 5786; https://doi.org/10.3390/cancers15245786
Available online: https://www.mdpi.com/2072-6694/15/24/5786

15. “Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors”
by Elisabetta Maria Abenavoli, Flavia Linguanti, Raffaella Calabretta, Roberto C. Delgado Bolton, Valentina Berti and Egesta Lopci
Cancers 2023, 15(23), 5675; https://doi.org/10.3390/cancers15235675
Available online: https://www.mdpi.com/2072-6694/15/23/5675

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

Five new journals covering multiple subjects have launched their inaugural issue in June 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all the Editorial Board Members and each journal will ensure its high-quality output using excellent editorial and rigorous peer review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal Topics (Selected)
	Prof. Dr. Marco Ranucci, IRCCS Policlinico San Donato, Italy | Editorial | view inaugural issue	anaesthetic medications; blood and fluid management; pain management; critical care; critical illness | view journal scope | submit an article
	Dr. Giovanni E. Cacciamani, University of Southern California, USA | Editorial | view inaugural issue	surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article
	Prof. Dr.  Gassan Hodaifa, Universidad Pablo de Olavide, Spain | Editorial | view inaugural issue	laboratory management; laboratory safety; protective equipment; laboratory problems and challenges; laboratory Innovation | view journal scope | submit an article
	Prof. Dr. Jan S. Suchodolski, Texas A&M University, USA | Editorial | view inaugural issue	companion animals health and disease; veterinary care and nutrition; genetics and genomics; behavior and welfare; human-animal relations | view journal scope | submit an article
	Prof. Dr. Pierfrancesco De Paola, University of Naples Federico II, Italy | Editorial | view inaugural issue	real estate appraisal; economic and financial valuation of real estate projects; sustainable real estate; housing and urban economics | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

June is designated as “Cancer Immunotherapy Awareness Month”, with various global activities to celebrate in this important month. Immunotherapy is a type of cancer treatment and can be used alone or in combination with chemotherapy and/or other cancer treatments. Taking this opportunity, we would like to extend our appreciation to all the researchers who have contributed to the fight against cancer. In particular, we would like to share some of the high-quality and innovative research findings in the field of cancer immunotherapy, published in Cancers (ISSN: 2072-6694).

We hope this announcement will provide useful information for this field.

“Recent Advances and Challenges in Cancer Immunotherapy”
by Chelsea Peterson, Nathan Denlinger and Yiping Yang
Cancers 2022, 14(16), 3972; https://doi.org/10.3390/cancers14163972
Available online: https://www.mdpi.com/2072-6694/14/16/3972

“Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis”
by Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso and Gennaro Palmiotti
Cancers 2022, 14(6), 1404; https://doi.org/10.3390/cancers14061404
Available online: https://www.mdpi.com/2072-6694/14/6/1404

“The New Era of Immunotherapy in Gastric Cancer”
by Shogo Takei, Akihito Kawazoe and Kohei Shitara
Cancers 2022, 14(4), 1054; https://doi.org/10.3390/cancers14041054
Available online: https://www.mdpi.com/2072-6694/14/4/1054

“BCG in Bladder Cancer Immunotherapy”
by Song Jiang and Gil Redelman-Sidi
Cancers 2022, 14(13), 3073; https://doi.org/10.3390/cancers14133073
Available online: https://www.mdpi.com/2072-6694/14/13/3073

“Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy”
by Jang Hyun Park and Heung Kyu Lee
Cancers 2022, 14(5), 1176; https://doi.org/10.3390/cancers14051176
Available online: https://www.mdpi.com/2072-6694/14/5/1176

“CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy”
by Rosanna Mezzapelle, Manuela Leo, Francesca Caprioglio, Liam S. Colley, Andrea Lamarca, Lina Sabatino, Vittorio Colantuoni, Massimo P. Crippa and Marco E. Bianchi
Cancers 2022, 14(9), 2314; https://doi.org/10.3390/cancers14092314
Available online: https://www.mdpi.com/2072-6694/14/9/2314

“Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives”
by Elisa Agostinetto, Filippo Montemurro, Fabio Puglisi, Carmen Criscitiello, Giampaolo Bianchini, Lucia Del Mastro, Martino Introna, Carlo Tondini, Armando Santoro and Alberto Zambelli
Cancers 2022, 14(9), 2136; https://doi.org/10.3390/cancers14092136
Available online: https://www.mdpi.com/2072-6694/14/9/2136

“Electroporation and Immunotherapy—Unleashing the Abscopal Effect”
by Tobias Freyberg Justesen, Adile Orhan, Hans Raskov, Christian Nolsoe and Ismail Gögenur
Cancers 2022, 14(12), 2876; https://doi.org/10.3390/cancers14122876
Available online: https://www.mdpi.com/2072-6694/14/12/2876

“Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer”
by Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García García, Vega Iranzo González-Cruz and Carlos Camps Herrero
Cancers 2022, 14(2), 307; https://doi.org/10.3390/cancers14020307
Available online: https://www.mdpi.com/2072-6694/14/2/307

“Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy”
by Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, Kazuki Maesaka, Takayuki Matsumae, Yoshiyuki Sawai, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka et al.
Cancers 2022, 14(4), 883; https://doi.org/10.3390/cancers14040883
Available online: https://www.mdpi.com/2072-6694/14/4/883

“How Did Conventional Nanoparticle-Mediated Photothermal Therapy Become “Hot” in Combination with Cancer Immunotherapy?”
by Wan Su Yun, Ji-Ho Park, Dong-Kwon Lim, Cheol-Hee Ahn, In-Cheol Sun and Kwangmeyung Kim
Cancers 2022, 14(8), 2044; https://doi.org/10.3390/cancers14082044
Available online: https://www.mdpi.com/2072-6694/14/8/2044

“Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes”
by Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco et al.
Cancers 2022, 14(10), 2429; https://doi.org/10.3390/cancers14102429
Available online: https://www.mdpi.com/2072-6694/14/10/2429

“Immunotherapy in Melanoma: Recent Advances and Future Directions”
by Andrew Knight, Lilit Karapetyan and John M. Kirkwood
Cancers 2023, 15(4), 1106; https://doi.org/10.3390/cancers15041106
Available online: https://www.mdpi.com/2072-6694/15/4/1106

“The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy”
by Yanlin Yu
Cancers 2023, 15(8), 2323; https://doi.org/10.3390/cancers15082323
Available online: https://www.mdpi.com/2072-6694/15/8/2323

“Chemo-Immunotherapy: A New Trend in Cancer Treatment”
by Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. Gonzalez-Rodriguez, Alejandra Martínez-Pérez, Juan P. Rodrigo, Juana M. García-Pedrero and Segundo Gonzalez
Cancers 2023, 15(11), 2912; https://doi.org/10.3390/cancers15112912
Available online: https://www.mdpi.com/2072-6694/15/11/2912

“Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome”
by Liying Li, Fan Zhang, Zhenyu Liu and Zhimin Fan
Cancers 2023, 15(1), 321; https://doi.org/10.3390/cancers15010321
Available online: https://www.mdpi.com/2072-6694/15/1/321

“FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects”
by Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Malik E. Juweid, Kamal Al-Rabi, Mohammad Ma’koseh, Hikmat Abdel-Razeq and Asem Mansour
Cancers 2023, 15(4), 1063; https://doi.org/10.3390/cancers15041063
Available online: https://www.mdpi.com/2072-6694/15/4/1063

“Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies”
by Justin H. Lo, Rajiv Agarwal, Laura W. Goff and Thatcher R. Heumann
Cancers 2023, 15(13), 3312; https://doi.org/10.3390/cancers15133312
Available online: https://www.mdpi.com/2072-6694/15/13/3312

“Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer”
by Hongzhong Jin, Shichong Liao, Feng Yao, Juanjuan Li, Zhiliang Xu, Kailiang Zhao, Ximing Xu and Shengrong Sun
Cancers 2023, 15(5), 1532; https://doi.org/10.3390/cancers15051532
Available online: https://www.mdpi.com/2072-6694/15/5/1532

“Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy”
by Vinith Johnson, Sunil Vasu, Uday S. Kumar and Manoj Kumar
Cancers 2023, 15(10), 2838; https://doi.org/10.3390/cancers15102838
Available online: https://www.mdpi.com/2072-6694/15/10/2838

“Decoding the Complexity of Immune–Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy”
by Kaitlyn Maffuid and Yanguang Cao
Cancers 2023, 15(16), 4188; https://doi.org/10.3390/cancers15164188
Available online: https://www.mdpi.com/2072-6694/15/16/4188

“From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy”
by Peter Vaupel, Helmut Piazena, Markus Notter, Andreas R. Thomsen, Anca-L. Grosu, Felix Scholkmann, Alan Graham Pockley and Gabriele Multhoff
Cancers 2023, 15(5), 1394; https://doi.org/10.3390/cancers15051394
Available online: https://www.mdpi.com/2072-6694/15/5/1394

“The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer”
by Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, Sara Bleve, Chiara Casadei, Cristian Lolli, Laura Ridolfi, Giovanni Martinelli and Ugo De Giorgi
Cancers 2023, 15(5), 1597; https://doi.org/10.3390/cancers15051597
Available online: https://www.mdpi.com/2072-6694/15/5/1597

“Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer”
by Clelia Madeddu, Silvia Busquets, Clelia Donisi, Eleonora Lai, Andrea Pretta, Francisco Javier López-Soriano, Josep Maria Argilés, Mario Scartozzi and Antonio Macciò
Cancers 2023, 15(4), 1076; https://doi.org/10.3390/cancers15041076
Available online: https://www.mdpi.com/2072-6694/15/4/1076

June is Cancer Survivors Month, which is a month-long observance that celebrates the strength, resilience, and triumph of those who have battled cancer. We would like to take this opportunity to express our gratitude to all of the researchers who have contributed to this field. In particular, we would like to share some of the innovative research findings in fields concerning cancer survivors, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information regarding this field.

1. “Clinician Perspectives on Palliative Care for People with Hepatocellular Carcinoma: Facilitators of and Barriers to Referral”
by Christopher D. Woodrell, Christie N. Mulholland, Nathan E. Goldstein, Carole L. Hutchinson, Thomas D. Schiano and Lissi Hansen
Cancers 2023, 15(14), 3617; https://doi.org/10.3390/cancers15143617
Available online: https://www.mdpi.com/2072-6694/15/14/3617

2. “Development Trajectories of Fatigue, Quality of Life, and the Ability to Work among Colorectal Cancer Patients in the First Year after Rehabilitation—First Results of the MIRANDA Study”
by Tomislav Vlaski, Marija Slavic, Reiner Caspari, Harald Fischer, Hermann Brenner and Ben Schöttker
Cancers 2023, 15(12), 3168; https://doi.org/10.3390/cancers15123168
Available online: https://www.mdpi.com/2072-6694/15/12/3168

3. “Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls”
by Kelly Nudelman, Kwangsik Nho, Michael Zhang, Brenna C. McDonald, Wanting Zhai, Brent J. Small, Claire E. Wegel, Paul B. Jacobsen, Heather S. L. Jim, Sunita K. Patel et al.
Cancers 2023, 15(11), 2877; https://doi.org/10.3390/cancers15112877
Available online: https://www.mdpi.com/2072-6694/15/11/2877

4. “Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer”
by Daniel Steffens, Natasha C. Pocovi, Jenna Bartyn, Kim Delbaere, Mark J. Hancock, Cherry Koh, Linda Denehy, Kimberley S. van Schooten, Michael Solomon and on behalf of the Priority Trial Collaboration
Cancers 2023, 15(9), 2434; https://doi.org/10.3390/cancers15092434
Available online: https://www.mdpi.com/2072-6694/15/9/2434

5. “Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients”
by Eva Warnecke, Maria Rosa Salvador Comino, Dilara Kocol, Bernadette Hosters, Marcel Wiesweg, Sebastian Bauer, Anja Welt, Anna Heinzelmann, Sandy Müller, Martin Schuler et al.
Cancers 2023, 15(11), 3029; https://doi.org/10.3390/cancers15113029
Available online: https://www.mdpi.com/2072-6694/15/11/3029

6. “Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison”
by Aasha I. Hoogland, Brent J. Small, Laura B. Oswald, Crystal Bryant, Yvelise Rodriguez, Brian D. Gonzalez, Xiaoyin Li, Michelle C. Janelsins, Hailey W. Bulls, Brian W. James et al.
Cancers 2023, 15(13), 3407; https://doi.org/10.3390/cancers15133407
Available online: https://www.mdpi.com/2072-6694/15/13/3407

7. “Outcomes Following Autologous Fat Grafting in Patients with Sequelae of Head and Neck Cancer Treatment”
by Jorge Masià-Gridilla, Javier Gutiérrez-Santamaría, Iago Álvarez-Sáez, Jorge Pamias-Romero, Manel Saez-Barba and Coro Bescós-Atin
Cancers 2023, 15(3), 800; https://doi.org/10.3390/cancers15030800
Available online: https://www.mdpi.com/2072-6694/15/3/800

8. “Delivering Palliative and Supportive Care for Older Adults with Cancer: Interactions between Palliative Medicine and Geriatrics”
by Alicia Castelo-Loureiro, Andrea Perez-de-Acha, Ana Cristina Torres-Perez, Vanessa Cunha, Paola García-Valdés, Paula Cárdenas-Reyes and Enrique Soto-Perez-de-Celis
Cancers 2023, 15(15), 3858; https://doi.org/10.3390/cancers15153858
Available online: https://www.mdpi.com/2072-6694/15/15/3858

9. “A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients”
by Francesca Serani, Wolfgang P. Fendler, Paolo Castellucci, Christoph Berliner, Francesco Barbato, Ken Herrmann, Andrea Farolfi and Stefano Fanti
Cancers 2023, 15(8), 2208; https://doi.org/10.3390/cancers15082208
Available online: https://www.mdpi.com/2072-6694/15/8/2208

10. “Gallbladder Cancer Risk and Indigenous South American Mapuche Ancestry: Instrumental Variable Analysis Using Ancestry-Informative Markers”
by Linda Zollner, Felix Boekstegers, Carol Barahona Ponce, Dominique Scherer, Katherine Marcelain, Valentina Gárate-Calderón, Melanie Waldenberger, Erik Morales, Armando Rojas, César Munoz et al.
Cancers 2023, 15(16), 4033; https://doi.org/10.3390/cancers15164033
Available online: https://www.mdpi.com/2072-6694/15/16/4033

11. “Stigma of Palliative Care among Patients with Advanced Cancer and Their Caregivers on Early Palliative Care”
by Elena Bandieri, Eleonora Borelli, Fabio Gilioli, Sarah Bigi, Claudia Mucciarini, Umberto Ferrari, Sonia Eliardo, Lidia Pinto, Carlo Adolfo Porro, Fabio Efficace et al.
Cancers 2023, 15(14), 3656; https://doi.org/10.3390/cancers15143656
Available online: https://www.mdpi.com/2072-6694/15/14/3656

12. “Impact of a Training Program on Oncology Nurses’ Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills”
by Doris Howell, Patrick McGowan, Denise Bryant-Lukosius, Ryan Kirkby, Melanie Powis, Diana Sherifali, Vishal Kukreti, Sara Rask and Monica K. Krzyzanowska
Cancers 2023, 15(6), 1811; https://doi.org/10.3390/cancers15061811
Available online: https://www.mdpi.com/2072-6694/15/6/1811

13. “Cognitive Sparing in Proton versus Photon Radiotherapy for Pediatric Brain Tumor Is Associated with White Matter Integrity: An Exploratory Study”
by Lisa E. Mash, Lisa S. Kahalley, Kimberly P. Raghubar, Naomi J. Goodrich-Hunsaker, Tracy J. Abildskov, Luz A. De Leon, Marianne MacLeod, Heather Stancel, Kelley Parsons, Brian Biekman et al.
Cancers 2023, 15(6), 1844; https://doi.org/10.3390/cancers15061844
Available online: https://www.mdpi.com/2072-6694/15/6/1844

14. “Impact of Surgical Care Bundle on Surgical Site Infection after Non-Reconstructive Breast Cancer Surgery: A Single-Centre Retrospective Comparative Cohort Study”
by Kian Chin, Fredrik Wärnberg, Anikó Kovacs and Roger Olofsson Bagge
Cancers 2023, 15(3), 919; https://doi.org/10.3390/cancers15030919
Available online: https://www.mdpi.com/2072-6694/15/3/919

You are welcome to submit relevant papers to the Cancers journal. For any questions, please feel free to contact us.

Cancers Editorial Office

MDPI will attend the ASHG Annual Meeting 2024, held in Denver, Colorado, USA, from 5 to 9 November 2024.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

• Genes;
• IJMS;
• Biomedicines;
• Diagnostics;
• Cancers;
• Biomolecules;
• Humans;
• Applied Biosciences;
• DNA;
• Cardiogenetics;
• Vaccines;
• Life;
• Epigenomes;
• Biology;
• CIMB;
• JCDD;
• ncRNA;
• Diseases;
• BioMed;
• Biomedinformatics.

If you plan on attending this conference, please stop by our booth #1058 and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following link: https://www.ashg.org/meetings/2024meeting/.

MDPI is pleased to announce the inclusion of 237 journals in the 2024 release of the Journal Citation Reports (JCR) and share the key results (see above).

This year, journals covered in the Emerging Sources Citation Index (ESCI) received category ranks together with journals in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). Overall, 139 MDPI journals indexed in ESCI are included in the new unified rankings for the first time.

Enhanced Comparability of Data

According to Clarivate, "the creation of unified category rankings [provides] a simpler and more complete category view for the evaluation of journal performance. [...] The category-first approach simplifies journal performance assessment with a holistic view of all journals in each subject category."

We are thrilled to announce that 72% of our ranked MDPI journals (171 of 237) are above average, in Q1 or Q2. Twenty-nine of our journals received their first Impact Factor this year, accounting for more than 5% of the journals accepted into the Web of Science last year.

MDPI Journals Ranked in JCR

The following data includes all MDPI journals indexed in SCIE, SSCI, ESCI and AHCI.

Source: 2023 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2024)

About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 440 fully open access titles.

We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to cancer pathophysiology in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant Special issue can be seen below.

“Histone Modification in Cancer”
Edited by Dr. Sibaji Sarkar
Viewed by 15000+ | Cited by 800+

“Advances in Oral Cancer: From Pathology to Treatment“
Edited by Prof. Dr. Andrea Santarelli
Viewed by 47000+ | Cited by 100+

“The Role of the Ubiquitin-Proteasome-System in Human Cancer“
Edited by Prof. Dr. Tarek Abbas
Viewed by 47000+ | Cited by 100+

“The Role of Hedgehog Pathway in Cancer”
Edited by Prof. Enrico De Smaele and Dr. Barbara Stecca
Viewed by 17000+ | Cited by 100+

“Lysophosphatidic Acid Signalling in Cancer”
Edited by Prof. Dr. David Brindley
Viewed by 55000+ | Cited by 200+

“Tumor and Metabolism”
Edited by Dr. Ángel Luis García-Otín and Dr. Patricia Sancho
Viewed by 45000+ | Cited by 100+

“The Dual Roles of Telomeres and Telomerase in Aging and Cancer”
Edited by Prof. Dr. Cagatay Günes
Viewed by 33000+ | Cited by 100+

“Hodgkin Lymphoma”
Edited by Prof. Sylvia Hartmann
Viewed by 50000+ | Cited by 100+

You are invited to view and submit relevant papers, proposals for some related Special Issues to the journal Cancers at the following link:

• https://www.mdpi.com/journal/cancers;
• https://www.mdpi.com/journalproposal/sendproposalspecialissue/cancers.

Cancers Editorial Office

Editor’s Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor’s Choice Articles related to cancer biomarkers, a curated list of high-quality articles from 2022 to 2023 in Cancers (ISSN: 2072-6694). The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice. The list of relevant papers can be seen below.

“Energy Sources for Exosome Communication in a Cancer Microenvironment”
by Abhimanyu Thakur, Amanda Johnson, Emily Jacobs, Kui Zhang, Jonathan Chen, Zhubo Wei, Qizhou Lian and Huanhuan Joyce Chen
Cancers 2022, 14(7), 1698; https://doi.org/10.3390/cancers14071698
Available online: https://www.mdpi.com/2072-6694/14/7/1698

“Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives”
by Fidan Seker-Polat, Nareg Pinarbasi Degirmenci, Ihsan Solaroglu and Tugba Bagci-Onder
Cancers 2022, 14(2), 443; https://doi.org/10.3390/cancers14020443
Available online: https://www.mdpi.com/2072-6694/14/2/443

“The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker”
by Lucrezia Togni, Vito Carlo Alberto Caponio, Nicoletta Zerman, Giuseppe Troiano, Khrystyna Zhurakivska, Lorenzo Lo Muzio, Andrea Balercia, Marco Mascitti and Andrea Santarelli
Cancers 2022, 14(15), 3571; https://doi.org/10.3390/cancers14153571
Available online: https://www.mdpi.com/2072-6694/14/15/3571

“The Role of Artificial Intelligence in Early Cancer Diagnosis”
by Benjamin Hunter, Sumeet Hindocha and Richard W. Lee
Cancers 2022, 14(6), 1524; https://doi.org/10.3390/cancers14061524
Available online: https://www.mdpi.com/2072-6694/14/6/1524

“Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer”
by Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García García, Vega Iranzo González-Cruz and Carlos Camps Herrero
Cancers 2022, 14(2), 307; https://doi.org/10.3390/cancers14020307
Available online: https://www.mdpi.com/2072-6694/14/2/307

“Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer”
by Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Jon Ramsell, Matilda Åslin, Emma Ivansson, Marta Lomnytska, Maria Lycke et al.
Cancers 2022, 14(7), 1757; https://doi.org/10.3390/cancers14071757
Available online: https://www.mdpi.com/2072-6694/14/7/1757

“Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion”
by Sophiya Siddiqui and Rainer Glauben
Cancers 2022, 14(1), 250; https://doi.org/10.3390/cancers14010250
Available online: https://www.mdpi.com/2072-6694/14/1/250

“The Evolution of Ovarian Carcinoma Subclassification”
by Martin Köbel and Eun Young Kang
Cancers 2022, 14(2), 416; https://doi.org/10.3390/cancers14020416
Available online: https://www.mdpi.com/2072-6694/14/2/416

“Peptide Receptor Radionuclide Therapy with [¹⁷⁷Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions”
by Maria I. del Olmo-García, Stefan Prado-Wohlwend, Pilar Bello, Angel Segura and Juan F. Merino-Torres
Cancers 2022, 14(3), 584; https://doi.org/10.3390/cancers14030584
Available online: https://www.mdpi.com/2072-6694/14/3/584

“Chemotherapy Side-Effects: Not All DNA Damage Is Equal”
by Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627
Available online: https://www.mdpi.com/2072-6694/14/3/627

“Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer”
by Stephanie N. Shishido, Salmaan Sayeed, George Courcoubetis, Hooman Djaladat, Gus Miranda, Kenneth J. Pienta, Jorge Nieva, Donna E. Hansel, Mihir Desai, Inderbir S. Gill et al.
Cancers 2022, 14(3), 758; https://doi.org/10.3390/cancers14030758
Available online: https://www.mdpi.com/2072-6694/14/3/758

“Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma”
by Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill and Shishir Shetty
Cancers 2022, 14(5), 1255; https://doi.org/10.3390/cancers14051255
Available online: https://www.mdpi.com/2072-6694/14/5/1255

“Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells”
by Jang Mi Han, Yu Jin Kim and Hye Jin Jung
Cancers 2022, 14(5), 1315; https://doi.org/10.3390/cancers14051315
Available online: https://www.mdpi.com/2072-6694/14/5/1315

“The Matrisome Is Associated with Metabolic Reprograming in Stem-like Phenotypes of Gastric Cancer”
by Ji-Yong Sung and Jae-Ho Cheong
Cancers 2022, 14(6), 1438; https://doi.org/10.3390/cancers14061438
Available online: https://www.mdpi.com/2072-6694/14/6/1438

“Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management”
by Sukanya Pati, Wadeed Irfan, Ahmad Jameel, Shahid Ahmed and Rabia K. Shahid
Cancers 2023, 15(2), 485; https://doi.org/10.3390/cancers15020485
Available online: https://www.mdpi.com/2072-6694/15/2/485

“Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer”
by Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol et al.
Cancers 2023, 15(11), 3020; https://doi.org/10.3390/cancers15113020
Available online: https://www.mdpi.com/2072-6694/15/11/3020

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to cancer causes, screening and diagnosis in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant Special issue can be seen below.

“Biophotonics and Imaging for Cancer Screening, Diagnosis and Treatment Monitoring”
Edited by Prof. Dr. Fiona Lyng
Viewed by 130000+ | Cited by 300+

“Artificial Intelligence and Advanced Medical Imaging in Cancer Diagnosis and Precision Care”
Edited by Prof. Dr. Reza Forghani
Viewed by 56000+ | Cited by 200+

“Uveal Melanoma: From Diagnosis to Therapy”
Edited by Prof. Dr. Emine Kilic
Viewed by 38000+ | Cited by 100+

“Theranostic Advances in Hepatobiliary Tumors”
Edited by Prof. Dr. Matias A. Avila
Viewed by 81000+ | Cited by 200+

“Diagnosis and Management of Endometrial Cancer”
Edited by Prof. Dr. Miguel Abal
Viewed by 52000+ | Cited by 100+

“Diagnosis and Treatment for Hepatocellular Tumors”
Edited by Prof. Dr. Georgios Germanidis
Viewed by 47000+ | Cited by 100+

“Recent Advances in Deep Learning and Medical Imaging for Cancer Treatment”
Edited by Prof. Dr. Muhammad Fazal Ijaz
Viewed by 56000+ | Cited by 100+

“Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers”
Edited by Prof. Dr. Florentia Dimitriou
Viewed by 25000+ | Cited by 100+

You are invited to view and submit relevant papers, proposals for some related special issues to the journal Cancers at the following link:

• https://www.mdpi.com/journal/cancers;
• https://www.mdpi.com/journalproposal/sendproposalspecialissue/cancers.

Cancers Editorial Office